A-657 - Predictors of clinical and pathological response in patients with basal cell carcinoma treated with BO-112, a novel intralesional treatment

EJC Skin Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles